share_log
Benzinga ·  Apr 29 08:57
AIM ImmunoTech Complete Safety Evaluation Of Patents Enrolled For Phase 1b/2 Study Of Ampligen And Imfinzi As Combination Therapy For Late-Stage Pancreatic Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment